Increased right ventricular afterload significantly increased the risk of 3-year all-cause mortality by 2.2-fold compared to normal right ventricular afterload in patients hospitalized with AECOPD (HR 2.172).
Cohort (n=652)
Single-blind
Yes
Does increased right ventricular afterload predict 3-year all-cause mortality in patients hospitalized with acute exacerbation of COPD?
Increased right ventricular afterload, detected via echocardiography, is a strong independent predictor of 3-year all-cause mortality in patients hospitalized with acute exacerbation of COPD.
Hazard Ratio: 2.172 (95% CI 1.384–3.411)
Absolute Event Rate: 22.8% vs 9.5%
p-value: p=<0.001
Purpose: The relationship between increased right ventricular (RV) afterload (moderate-to-high suspicion of pulmonary hypertension indicated by echocardiography) and the prognosis of patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is not yet well understood. Patients and Methods: This prospective cohort study was conducted in 11 hospitals from 2017 to 2020, involving patients hospitalized with AECOPD. Echocardiography was performed within 48 hours of admission. Patients were classified into two groups: those with increased RV afterload (n=237) and those with normal RV afterload (n=415). Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox regression analysis to evaluate the impact of RV afterload on patient outcomes. Kaplan-Meier survival curves were employed to assess the association between RV afterload and 3-year all-cause mortality. Results: Kaplan-Meier survival curves demonstrated that the 3-year all-cause mortality rates were 22.8% in AECOPD patients with increased RV afterload and 9.5% in those with normal RV afterload. Cox regression analysis indicated that increased RV afterload is an independent predictor of poor prognosis in hospitalized AECOPD patients, significantly increasing the risk of 3-year all-cause mortality (HR=2.172, 95% CI: 1.384– 3.411; P < 0.001). Additionally, elevated brain natriuretic peptide (BNP) or n-terminal pro-brain natriuretic peptide (NT-proBNP) (HR=2.694, 95% CI: 1.724– 4.209; P < 0.001), and lower body mass index (BMI) (HR=0.880, 95% CI: 0.833– 0.930; P < 0.001) were independent risk factors for mortality. Conclusion: Increased RV afterload is associated with a significant increase in the risk of 3-year all-cause mortality in patients hospitalized with AECOPD, posing a 2.2-fold higher risk compared to those with normal RV afterload. It also stands as an independent risk factor for mortality. Elevated BNP or NT-proBNP levels and reduced BMI are additional independent risk factors of mortality. Early detection of these three risk factors could play a role in stratifying high-risk patients, guiding clinical decision-making, and improving patient outcomes in AECOPD. Plain Language Summary: In this study, we focused on individuals hospitalized for AECOPD. We investigated the association between moderate-to-high suspicion of pulmonary hypertension on echocardiography and their prognosis. Our results can help identify those at high risk of mortality. Echocardiography is a noninvasive and widely available tool, yet its validation in large real-world cohorts remains limited. Moreover, many people are hospitalized for AECOPD, and our findings apply to the much larger population seen in primary care and routine clinical practice. Keywords: respiratory diseases, echocardiography, mortality, n-terminal pro-brain natriuretic peptide/brain natriuretic peptide, body mass index
Gao et al. (Mon,) conducted a cohort in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) (n=652). Increased right ventricular afterload vs. Normal right ventricular afterload was evaluated on 3-year all-cause mortality (HR 2.172, 95% CI 1.384-3.411, p=<0.001). Increased right ventricular afterload significantly increased the risk of 3-year all-cause mortality by 2.2-fold compared to normal right ventricular afterload in patients hospitalized with AECOPD (HR 2.172).